Influenza
Not recruitingStudy of mRNA-1010 Influenza Vaccine Compared to Standard Flu Vaccine in Adults 50 Years and Older
Germany- Participants:18–64 years · 65+ years
- Substances:Cx-037231
- Sponsor:Moderna Inc.
Rare diseases
Investigational molecules
Locations
Back to Germany15 clinical trials in Stuhr, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)
Germany
Germany
GermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical studies focusing on respiratory viral infections and respiratory tract conditions, including trials for preventive vaccines and treatments.
Research includes evaluation of herbal medicinal products and next-generation vaccine technologies for older adults.
Comprehensive research targeting atherosclerotic cardiovascular disease and related conditions, with emphasis on innovative therapeutic approaches.
Studies focus on reducing major adverse cardiovascular events and improving patient outcomes through novel drug combinations.
Specialized trials investigating treatments for atrial fibrillation and related cardiac rhythm disorders, emphasizing stroke prevention.
Research aims to evaluate new therapeutic options for preventing cardiovascular complications in atrial fibrillation patients.
Tell us about your condition – we search every trial in Europe and connect you with the right site.